Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D

Cosmo Technologies Ltd · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
diarrhea-predominant irritable bowel syndrome, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804785
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.